Keyphrases
Neurodegeneration
100%
Early Life Adversity
100%
Adrenergic Signaling
100%
Multiple Sclerosis Model
100%
Trauma Triggers
100%
Interferon Resistance
100%
Immune Cells
42%
Phenotypic Change
42%
Experimental Autoimmune Encephalomyelitis
42%
Multiple Sclerosis
28%
Adrenergic Receptors
28%
Environmental Impact
14%
Well-defined
14%
Receptor Function
14%
Adrenergic Receptor Antagonist
14%
Environmental Triggers
14%
Multiple Sclerosis Treatment
14%
Agonist Treatment
14%
CXCR2
14%
Relapse Rate
14%
Lymphotoxin
14%
Adrenergic Receptor Agonists
14%
Disease Heterogeneity
14%
Biochemistry, Genetics and Molecular Biology
interferon
100%
Interferon
100%
Adrenergic Receptor
100%
Mouse
75%
Immunocompetent Cell
75%
Downregulation
50%
Receptor Agonists
25%
Receptor Antagonist
25%
Norepinephrine
25%
Lymphotoxin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Injury
100%
Interferon
100%
Multiple Sclerosis
100%
Nerve Degeneration
100%
Mouse
42%
Experimental Allergic Encephalitis
42%
Adrenergic Receptor
28%
Disease
14%
Noradrenalin
14%
Adrenergic Receptor Stimulating Agent
14%
Adrenergic Receptor Blocking Agent
14%
Recurrence Risk
14%
Lymphotoxin
14%
Neuroscience
Interferon
100%
Neurodegeneration
100%
Multiple Sclerosis
100%
Adrenergic Receptor
75%
Encephalitis
75%
Receptor Antagonist
25%
Norepinephrine
25%
Sympathomimetic Drug
25%
Immunology and Microbiology
interferon
100%
Multiple Sclerosis
100%
Mouse
75%
Immunocompetent Cell
75%
Experimental Allergic Encephalitis
75%
Downregulation
50%
Agonist
25%
Lymphotoxin
25%